Home Site Map Contact Us Join ASA Members Only
 
ASA NEWSLETTER
 
 
May 2000
Volume 64
Number 5
   
Cognitive Function After Non-Brain Surgery Studied: Second Duke Conference on Surgery and the Elderly

Madan M. Kwatra, Ph.D.


It is well known that the elderly population in the United States is increasing rapidly, and the implications of this trend for surgery on the elderly are being examined. Five years ago, Duke University Medical Center established the Gerontological Research in Anesthesiology and Surgery Program (GRASP) to identify areas of basic and clinical research that will reduce the incidence of adverse postsurgical outcomes in the elderly. In addition to holding monthly meetings and developing research projects, GRASP organizes biennial conferences on surgery and the elderly. The second such conference was held at Duke University Medical Center on September 30, 1999. Titled "Cognitive Function After Surgery: What Do We Know? What Do We Need to Know?," the conference brought together anesthesiologists, basic scientists, geriatricians and surgeons. It was co-hosted by Duke's departments of anesthesiology, surgery and the Duke Center for the Study of Aging and Human Development. Funding was provided by the American Geriatrics Society/John A. Hartford foundation and Abbott Laboratories.

Ronnie Rosenthal, M.D., Yale University, New Haven, Connecticut, said that the percentage of surgeries performed on people over the age of 65 (currently at 40 percent) will increase substantially over the coming decades as the elderly population increases. Although surgery is beneficial even for octogenarians, the incidence of adverse outcomes is much higher due to existing co-morbidities. Dr. Rosenthal provided data implicating nutritional status measured by serum albumin levels and intraoperative hypothermia as the two most important factors affecting postoperative outcomes. Further, she reported that the incidence of major complications including deaths were significantly higher in patients that have postoperative delirium.

Paula Trzepacz, M.D., who is affiliated with Eli Lilly, distinguished delirium from dementia. The hallmarks of delirium are disorientation, attentional deficits and clouding of consciousness. Demented patients, on the other hand, can pay attention but cannot remember. Delirium also develops over a short period of time (hours or a day), whereas most dementias develop over a longer period. The risk factors for delirium in the perioperative period include advanced age, male gender, history of alcoholism, polypharmacy (especially anticholinergic agents), pre-existing dementia or cognitive impairment, metabolic disturbances and low serum albumin.

Three presentations focused on cognitive dysfunction after cardiac, hip and other surgeries. Mark Newman, M.D., Duke University, Durham, North Carolina, discussed his team's study that followed cognitive function up to five years after cardiac surgery. Cognitive dysfunction affected more than half the patients at discharge; this incidence fell to 20-24 percent at six months, but increased to 42 percent at five years. The most significant predictor of cognitive dysfunction at five years was impairment at discharge. To better understand the mechanism of cognitive dysfunction after cardiac surgery, a rat model of cardiopulmonary bypass has been developed by Hilary Grocott, M.D., at Duke University.

Kenneth Koval, M.D., New York University, New York, New York, presented data on functional outcomes after hip fractures in patients over the age of 65 who were cognitively intact and lived in community dwellings. In a sample of 921 hip fracture patients, the incidence of postoperative delirium was 5 percent, a much lower rate than that reported by other investigators, possibly reflecting different definitions used for detecting delirium. The predictors of postoperative delirium in this population were gender (male) and general anesthesia.

Terri G. Monk, M.D., University of Florida, Gainesville, Florida, presented details on the International Study of Postoperative Cognitive Dysfunction (ISPOCD) published in The Lancet in 1998.1 Postoperative cognitive dysfunction occurred in 25 percent of patients in the first week after surgery and in 10 percent of patients within three months of surgery. More importantly, the ISPOCD study found that patients over the age of 70 were more susceptible to prolonged cognitive decline after surgery than those in their early 60s. Dr. Monk is currently examining whether the multicenter findings apply to a single institution using ISPOCD methodology, by evaluating 1,500 patients.

Pamela Williams-Russo, M.D., Cornell University, Ithaca, New York, addressed the question of anesthetic technique and cognitive outcome. Because patients undergoing regional anesthesia are alert and awake during and immediately after surgery, it is likely that regional anesthesia could result in less postoperative cognitive dysfunction than general anesthesia. However, the available literature does not provide a clear answer to this hypothesis. Dr. Williams-Russo presented data on a randomized trial of the effects of epidural versus general anesthesia on cognitive dysfunction in 262 older adults (85 percent over the age of 60 and 50 percent over the age of 70) undergoing elective primary total knee replacement.2 The two anesthesia groups were compared for change in neurocognitive function prior to surgery to six months after surgery using a comprehensive neuropsychologic testing battery. No significant difference in the incidence of postoperative dysfunction was detected between the two groups.

Alexis Carmer, M.D., Duke University, Dunham, North Carolina, discussed an abstract (presented by Stephan A. Schug, M.D., at the 1999 meeting of the American Society of Regional Anesthesia and Pain Medicine) on a meta-analysis comparing regional versus general anesthesia in 107 different trials consisting of more than 8,000 patients. Regional anesthesia patients had a one-third less mortality rate and a significant decrease in the incidence of deep venous thrombosis, pulmonary embolism, pneumonia and respiratory depression. These differences in outcomes, Dr. Carmer suggested, could affect cognitive dysfunction. The group consensus, however, was that anesthesia type does not seem to influence the incidence of cognitive dysfunction, but a larger prospective randomized controlled trial focusing on older patients is warranted to definitively answer this crucial question.

Dr. Trzepacz focused on the cholinergic mechanisms of postoperative delirium. She reviewed the brain areas involved in delirium and highlighted a key role of acetylcholine in the REM sleep, arousal, mood and memory changes seen in delirium.3 Anticholinergic drugs are known to cause delirium. Dopamine may also cause delirium through acetylcholine because it acts through D2 receptors and reduces acetylcholine levels. Opiates also cause delirium as they are known to reduce acetylcholine and increase dopamine. Madan M. Kwatra, Ph.D., presented biochemical information on the enzymes and receptors involved in the function of acetylcholine and how the various components of the cholinergic system are affected with age and anesthetics. Muscarinic receptors, a key target through which acetylcholine produces its action, become desensitized with age.4 Further, anesthetics are known to disrupt muscarinic receptor-G protein coupling.5 Whether the cholinergic system of elderly patients is more susceptible to the detrimental effects of anesthetics is an important question that needs to be addressed.

Lively discussions following the talks identified three key problems. First, the very term "cognitive dysfunction" is confusing. Is it delirium or dementia or both? Precise standard definitions are sorely needed. Second, researchers have used a variety of instruments to detect cognitive dysfunction. Standardization of instruments is needed so that studies from different institutions can be adequately compared. The group consensus was that a standardized and validated delirium score be developed for use in all surgical patients. Finally, many studies have focused on populations consisting of a large portion of patients who are 60 or 65 years old. Since this age group is relatively healthy, more trials should be performed on patients over the age of 75. This group will present the greatest challenge to anesthesiologists.


References:

1. Moller JT, et al. Long-term postoperative cognitive dysfunction in the elderly. ISPOCDI study. Lancet. 1998; 351:857-861.
2. Williams-Russo P, Sharock NE, Mattis S, et al. Cognitive effects after epidural vs. general anesthesia in older adults. A randomized trial. JAMA. 1995; 274(1):44-50.
3. Trzepacz PT. Anticholinergic model for delirium. Semin Clin Neuropsychiatry. 1996; 1(4):294-303.
4. Anson RM, Cutler R, Joseph JA, et al. The effects of aging on muscarinic receptor/G-protein coupling in the rat hippocampus and striatum. Brain Res. 1992; 598:302-306.
5. Anthony BL, Dennison RL, Aronstam RS. Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett. 1989; 99:191-196.

Madan M. Kwatra, Ph.D., is Associate Professor of Anesthesiology and Assistant Professor of Pharmacology and Cancer Biology at Duke University. He is also Coordinator of the Gerontological Research in Anesthesia and Surgery Program (GRASP) and Senior Fellow of the Center for the Aging and Human Development, Duke University Medical Center, Durham, North Carolina.



return to top

Home >Newsletters >May 2000Home >Test

 


FEATURES

The Aging of America: Anesthesiology Redefines Its Role


ARTICLES


DEPARTMENTS


The views expressed herein are those of the authors and do not necessarily represent or reflect the views, policies or actions of the American Society of Anesthesiologists.

NL Archives

Search the ASA Newsletter

Information for Authors